Aurora Cannabis (NYSE:ACB) has been under extreme pressure as the rout in cannabis stocks continues to take its toll. It highlights just how important it is to use discipline when it comes to investing. That’s true for Aurora Cannabis stock, just as it is for a company like Apple (NASDAQ:AAPL).
Global regulators have been moving to a more accepting approach of cannabis, both recreationally and medically. However, while that may be a long-term catalyst for the industry, it hasn’t stopped the short- to intermediate-term rout this group (including names such as Aphria (NYSE:APHA), Canopy Growth (NYSE:CGC)) has experienced.